Guardant Health sues rival Natera over cancer-testing trade secrets
Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...
Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high ...
Volta Labs, a leading genomics applications company, and Ginkgo Bioworks, (NYSE: DNA), which is building a leading platform for cell programming and biosecurity, today announced the integration of the ...
来自MSN5 小时
Oxford BioDynamics to Announce Year-End Financial Results
Oxford BioDynamics ( ($GB:OBD) ) just unveiled an announcement. Oxford BioDynamics Plc announced it will release its financial results for the ...
openaccessgovernment9 小时
The future of genomic sequencing for cancer diagnosis and treatment
The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...
eLife18 小时
Structure-guided secretome analysis of gall-forming microbes offers insights into effector ...
This study presents an important discovery regarding the diversity and evolution of gall-forming microbial effectors. Supported by convincing computational structural predictions and analyses, the ...
Roche unveils its breakthrough proprietary SBX technology
Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...
manilatimes23 小时
Roche unveils a new class of next-generation sequencing with its novel sequencing by ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), ...
Science Daily23 小时
Almost 90% of people would agree to genetic testing to tailor medication use, survey finds
New research shows almost 90% of people in England would agree to genetic testing to get the most effective medication and reduce the risk of side effects.